Clinical Trial Update: Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating bupropion for fatigue in patients with end-stage renal disease on hemodialysis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Fatigue

Drugs mentioned

• bupropion (bupropion)

Snippet

Sponsor: The University of Texas Health Science Center at San Antonio | Conditions: End Stage Renal Disease, Fatigue | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING